Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Consolidated Net Income (2016 - 2026)

Organogenesis Holdings has reported Consolidated Net Income over the past 10 years, most recently at $53.2 million for Q4 2025.

  • For Q4 2025, Consolidated Net Income rose 593.34% year-over-year to $53.2 million; the TTM value through Dec 2025 reached $46.5 million, up 5304.41%, while the annual FY2025 figure was $46.5 million, 5304.41% up from the prior year.
  • Consolidated Net Income for Q4 2025 was $53.2 million at Organogenesis Holdings, up from $21.6 million in the prior quarter.
  • Over five years, Consolidated Net Income peaked at $53.2 million in Q4 2025 and troughed at -$18.8 million in Q1 2025.
  • A 5-year average of $8.2 million and a median of $6.5 million in 2023 define the central range for Consolidated Net Income.
  • Biggest five-year swings in Consolidated Net Income: surged 1450.88% in 2024 and later plummeted 797.29% in 2025.
  • Year by year, Consolidated Net Income stood at $51.0 million in 2021, then plummeted by 81.44% to $9.5 million in 2022, then tumbled by 106.0% to -$568000.0 in 2023, then surged by 1450.88% to $7.7 million in 2024, then skyrocketed by 593.34% to $53.2 million in 2025.
  • Business Quant data shows Consolidated Net Income for ORGO at $53.2 million in Q4 2025, $21.6 million in Q3 2025, and -$9.4 million in Q2 2025.